Abstract: A process and apparatus is provided for separating whole blood from a patient into a cellular component and a plasma component and for separating the plasma component into a high molecular weight plasma fraction and a low molecular weight plasma fraction and wherein anticoagulant is added to the whole blood and a physiologically acceptable liquid diluent is added to the plasma component. The rate of addition of the diluent is governed by the following equation: ##EQU1## called Equation 1.
Type:
Grant
Filed:
February 10, 1986
Date of Patent:
March 1, 1988
Assignee:
Millipore Corporation
Inventors:
Anthony J. DiLeo, Gaston de los Reyes, Lisa M. Waranch
Abstract: Compounds of the formula:M(NR.sup.1)(OR.sup.2).sub.2 (CHR.sup.3)whereinM is molybdenum or tungsten;R.sup.1 and R.sup.2 are alkyl, aryl, aralkyl or halogen-substituted derivatives or silicon-containing analogs thereof;R.sup.3 is an alkyl, aryl, aralkyl or any substituent that results from the initial reaction between the M.dbd.CHR.sup.3 complex and the olefin(s) that is(are) being metathesized;alkyl has 1-20 carbons, aryl has 6-20 carbons and aralkyl has 7-20 carbons.These compounds are catalysts for the metathesis of ordinary olefins (hydrocarbons) and especially functionalized olefins in the homogeneous phase.
Abstract: One or both surfaces of a uniformly and completely textured polyimide sheet are coated with a layer of electroless nickel or cobalt and a subsequent layer of electrolytically applied copper yielding an adhesiveless laminate useful in the production of electronic circuitry. The copper and nickel or cobalt layers are strongly bonded to the textured polyimide sheet to the extent that the laminate exceeds bond strength requirements as measured by current standard peel strength tests of the Institute for Interconnecting and Packaging Electronic Circuits (IPC) for both initial and post solder float adhesion.
Abstract: A zinc-aluminum alloy coating having desirable ductile properties and a uniform fine grain structure having excellent wettability for a ferrous metal substrate comprises greater than about 25 percent by weight aluminum and zinc, wherein the alloy further includes from about 0.1 to about 1.0 percent by weight of a rare earth alloy for enhancing the wettability of the alloy to the ferrous metal and the balance comprises additional additives and impurities. With alloys having increased concentration of aluminum, the solubility of the rare earth alloy is increased, thereby increasing wettability.
Abstract: Human antibodies are provided by collecting the mononuclear cells from human blood, removing suppressor T-cells and exposing the remaining lymphocyte cells to an antigen, autologous serum of the human patient and a nonspecific lymphocyte activator.
Abstract: A composition comprising tryptophan and melatonin with or without an insulin-releasing carbohydrate or melatonin and an insulin-releasing carbohydrate is administered to an animal in order to increase the levels or release of brain serotonin.
Abstract: A process for forming a purified solute from an aqueous solution is provided whereby a mixture of an extractant, a hydrate former and the aqueous solution is first formed. The hydrate former forms a hydrate with water while the solute does not form a hydrate. The extractant takes up the solute from the aqueous solution. The mixture is subjected to a temperature and pressure sufficient to form the solid hydrate of the hydrate former, an aqueous solution of the solute and a portion comprising the extractant containing the solute. The solute is recovered from the portion comprising the extractant and the solute.
Type:
Grant
Filed:
June 12, 1986
Date of Patent:
July 7, 1987
Assignee:
Massachusetts Institute of Technology
Inventors:
Richard C. Willson, III, Eric Bulot, Charles L. Cooney
Abstract: A novel method for detecting and isolating DNA sequences commonly held by different DNA preparations or repeated or amplified within a complex genome has been provided. The DNA preparations of interest are digested with the same restriction enzyme and a portion of at least one preparation is labeled with .sup.32 P. The labeled and unlabeled DNA preparations are combined and electrophoresed in an agarose gel. Following electrophoresis, the DNA is denatured in situ and allowed to reanneal within the gel so that homologous DNA sequences present within restriction fragments of the same size can reanneal. After reannealing, unhybridized single-stranded DNA is digested in situ followed by detection of the reannealed DNA by autoradiography. When labeled and unlabeled DNAs are derived from different DNA preparations, only the restriction fragments commonly held by these two preparations are detected.
Abstract: A multi-dose container for radio-isotopes comprises a body having a cover. The cover contains a slidable portion which opens to reveal a small opening for withdrawing the contents of the container. The slidable portion is spring loaded and locks in the open position by engaging holding means formed on the cover. The cover contains a release bar which, when pressed, removes the holding means from engagement with the slidable portion and allows the spring to return the slidable portion to a closed position. The operation can easily be performed with one hand.
Abstract: Tyrosine or a tyrosine precursor is administered concomitantly with an indirect-acting sympathomimetic amine drug to increase the level of norepinephrine that can be released in sympathetic neuron synapses.
Abstract: Amines, including proteins and polypeptides covalently coupled with a chelating agent such as diethylenetriaminepentaacetic acid (DTPA) can be labeled with .sup.99m Tc in the presence of a stannous reducing agent at near neutral pH by maintaining the protein concentration at a low level and the DTPA concentration at a high level. The .sup.99m Tc is labeled to the protein through the DTPA sites linked to the protein. Utilizing .sup.111 In labeled proteins as controls, it is shown that the .sup.99m Tc labeled proteins are labeled at the DTPA sites and that they exhibit in vivo stabilities equal to that of the .sup.111 In labeled proteins.
Abstract: A multilayered composite product useful as an electrical circuit is produced by coating a base with a photoimagable resin free of catalyst or catalyst activator for electroless metal deposition. The resin is patterned by exposure to a desired light, through a mask followed by development. The patterned cured resin is selectively chemically modified while avoiding chemical modification of the base to render the cured resin receptive to a metal catalyst. The metal catalyst which promotes subsequent electroless metal deposition is selectively absorbed on the patterned cured resin and is converted to a catalytically active form. A conductive metal then is deposited selectively on the catalyst-containing patterned cured resin.
Type:
Grant
Filed:
October 30, 1985
Date of Patent:
May 19, 1987
Assignee:
Polyonics Corporation
Inventors:
Merwin F. Hoover, Ann B. Salamone, Jan Vandebult
Abstract: A rapid method for determining the isoelectric point for an amphoteric molecule of interest is provided which utilizes the pH-dependent binding affinity of the molecule for an ion-exchange material. The empirically derived pI values are within a range of 0.2 pH units or less of the reported values in the literature and may be more precisely determined by employing a narrower pH gradient as part of the procedure. The unique methodology allows isoelectric point determinations to be accomplished within one hour's time, avoids carrier ampholyte interaction or artifact formation, and allows the determination to be performed at any desired temperature with decreased risk of denaturation.
Abstract: Cataract in mammalian lenses can be prevented or reversed by applying a solution of an imidoester, a N-hydroxysuccinimide-ester or hydrogen peroxide to the lens under conditions that permit the solution to interact with the lens constituents.
Type:
Grant
Filed:
March 21, 1985
Date of Patent:
May 12, 1987
Assignee:
Massachusetts Institute of Technology
Inventors:
Roelant J. Siezen, Christophe M. Coppin, George B. Benedek
Abstract: New purine compounds having the formula: ##STR1## Y and Y'=H, ##STR2## X=H, alkyl, halo; ##STR3## A=O, S, NH.sub.2 are provided. These compounds are useful in treating patients having cancer, since they are potent and selective inhibitors of replicative DNA synthesis in mammalian cells since they inhibit DNA polymerase .alpha..New purine compounds also are provided having the formula: ##STR4## wherein Y, A, Z are as defined above, X'=C.sub.2 H.sub.5 Y"=--CH.sub.3 or ##STR5## These compounds are useful to prevent bacterial growth since they are potent inhibitors of DNA polymerase III.New Purine compounds also are provided having the formula: ##STR6## wherein Z' is H, OH or CH.sub.2 OH,A' is O of CH.sub.
Abstract: A composition such as a biologically active substance is delivered upon demand from a polymeric matrix by exposing the polymeric matrix containing the composition to ultrasonic energy.
Abstract: Apparatus is provided for converting rotational motion to linear motion which includes a screw shaft and nut surrounding the screw shaft, each having a helical thread. A plurality of threaded planetary rollers is interposed between and in contact with the threads of the screw shaft and nut. The screw shaft has a different number of starts than the number of starts on the nut.
Abstract: D-fenfluramine is administered to a human patient having seasonal depression or other forms of bipolar depression in order to alleviate or cure the depression.
Type:
Grant
Filed:
June 16, 1986
Date of Patent:
March 10, 1987
Assignee:
Massachusetts Institute of Technology
Inventors:
Richard J. Wurtman, Judith J. Wurtman, Dermot O'Rourke
Abstract: An electrical generating plant of high efficiency utilizes a conventional steam plant powered by a fossil fuel such as coal, gas or oil, in internal integration with a high temperature solid-oxide fuel-cell. In one embodiment, the spent fuel and the wast heat from the fuel-cell of electrochemical action is made directly available to the combustion furnace of the steam plant for thermodynamic extraction. The system can achieve efficiencies up to 65% compared to ordinary steam plants which have an efficiency of about 35%.